ClinicalTrials.gg
CompletedNCT04761380Updated Feb 18, 2021

Decreased Tongue Strength is Related to Skeletal Muscle Mass in COPD Subjects

An observational study in Chronic Obstructive Pulmonary Disease, sponsored by Kindai University. Completed at 1 site in Japan. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-02-18.

Sponsored by Kindai University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
51
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 108 studies in Pulmonary Disease, Chronic Obstructive with a site in Japan — 13 open to participants now, 16 under way, 8 of them phase 3. Pulmonary Disease, Chronic Obstructive · Japan.

Enrollment
20th of 20
51 · median 709
Started
2019
with 5 others
Observational
20 of 108
2 open now
Registered
82nd of 108
by date

Among the 108 studies in Pulmonary Disease, Chronic Obstructive with a site in Japan, this one is the 20th largest by enrollment of the 20 observational ones that give a count, is one of 6 that started in 2019, is one of 20 observational ones, and was the 82nd registered.

Pulmonary Disease, Chronic Obstructive

5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.

Browse Pulmonary Disease, Chronic Obstructive studies →

Open to participants now

13 of the 108 studies in Pulmonary Disease, Chronic Obstructive with a site in Japan are open now. Recruiting first, the newest first:

8 more — sign in →

All 13 open studies →

A study can be open while its sites in Japan have not opened yet or have stopped. Only those recruiting at a site in Japan →

Who these studies take

Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 108 studies in Pulmonary Disease, Chronic Obstructive with a site in Japan, or all of them as a file.
02

Study summary

Background:

Dysphagia is frequently observed in subjects with chronic obstructive pulmonary disease (COPD). But tongue strength has not been investigated yet in COPD subjects. The investigators hypothesized that tongue strength is weaker in COPD subjects compared to normal subjects.

Methods:

This was a single-centre, observational, and cross-sectional study. Twenty-seven subjects with COPD and twenty-four age-matched control subjects were enrolled in this study. Isometric tongue strength was measured using a device fitted with a disposable oral balloon probe. The investigators also evaluated handgrip strength, gait speed, and appendicular skeletal muscle mass (ASM) to define participants as having sarcopenia. ASM, fat free mass index (FFMI), and skeletal muscle mass index (SMI) were measured by bioelectrical impedance analysis. Gait speed was measured using the 6-meter walking test. The eating assessment test-10 (EAT-10) was used to diagnose dysphagia.

03

Conditions studied

  • Chronic Obstructive Pulmonary Disease

Keywords

  • dysphagia
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

COPD subjects were chosen from a group of subjects who had visited the Department of Respiratory Medicine and Allergology at Kindai University Hospital from December 2019 to May 2020.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of stable .
  • Age-matched control subjects who did not have any pulmonary disease.

Exclusion criteria

Exclusion Criteria:

  • Participants with metallic implants.
  • History of stroke disease.
  • History of neuromuscular disease.
  • Participants who did not have their front teeth.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
51 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • stable COPD subjects

    Diagnostic Test: balloon-based tongue pressure measurement device

  • age-matched control subjects subjects who did not have any pulmonary disease

    Diagnostic Test: balloon-based tongue pressure measurement device

Interventions

  • Diagnostic testballoon-based tongue pressure measurement device

    The probe was inflated at a baseline pressure of 19.6 kilopascal (kPa). To measure MTP, the balloon was positioned on the anterior palate with the lips closed. Subjects raised their tongue and compressed the balloon onto the palate with maximal voluntary muscular effort for approximately 7s. The measurement was taken three times with a 1-min interval. The maximum value was recorded as the MTP.

    Also known as: Bioelectrical impedance analysis

06

What researchers measure

Primary outcomes

  1. maximum tongue pressure

    To measure maximum tongue pressure (MTP), the balloon was positioned on the anterior palate with the lips closed. Subjects raised their tongue and compressed the balloon onto the palate with maximal voluntary muscular effort for approximately 7s. The measurement was taken three times with a 1-min interval. The maximum value was recorded as the MTP.

    Time frame: 1 day

Secondary outcomes

  1. handgrip strength

    Handgrip strength was measured three times for the right hand using a grip strength dynamometer and mean values were used.

    Time frame: 1 day

  2. fat free mass index (FFMI)

    FFMI (kg/m\^2) was calculated by fat free mass/height\^2(m\^2).

    Time frame: 1 day

  3. skeletal muscle mass (SMI)

    SMI (kg/m\^2) was calculated by skeletal muscle mass /height\^2(m\^2).

    Time frame: 1 day

  4. fat free mass

    Fat free mass was measured using the medical body composition analyzer. It is designed for measurements in the supine position, using four pairs of electrodes (eight electrodes in total), positioned on each hand and foot21. Supine measurements were taken after lying down for 10 minutes. Alcohol was prohibited for 24h prior to the impedance measurements.

    Time frame: 1 day

  5. skeletal muscle mass

    Skeletal muscle mass was measured using the medical body composition analyzer. It is designed for measurements in the supine position, using four pairs of electrodes (eight electrodes in total), positioned on each hand and foot21. Supine measurements were taken after lying down for 10 minutes. Alcohol was prohibited for 24h prior to the impedance measurements.

    Time frame: 1 day

  6. height

    Time frame: 1 day

07

Study locations

1 site
  • Kindai University Faculty of Medicine
    Ōsaka-sayama, Osaka 5898511, Japan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2019 to primary completion in May 2020, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 9, 2020
First posted
Feb 18, 2021
StartActual
Dec 1, 2019
Primary completionActual
May 10, 2020
CompletionActual
May 10, 2020
Last update
Feb 18, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 18, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04761380
Lead sponsor
Kindai University
Responsible party
Sponsor
First posted
Feb 18, 2021
Start date
Dec 1, 2019
Primary completion
May 10, 2020
Completion
May 10, 2020
Last update
Feb 18, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion